| Issuer | % of Class | Filed | ||||
|---|---|---|---|---|---|---|
| Schedule 13G · 1 security · passive | ||||||
|
Cyclerion Therapeutics, Inc.
13G/A
CYCN · 23255M105
|
0% |
2/12/2025
Event 12/31/2024
|
||||
| MFN Partners, LP | 0% | |||||
| MFN Partners GP, LLC | 0% | |||||
| MFN Partners Management, LP | 0% | |||||
| MFN Partners Management, LLC | 0% | |||||
| Michael F. DeMichele | 0% | |||||
| Farhad Nanji | 0% | |||||
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.